Results for tag: "Dasatinib"

Dasatinib is a type of leukemia drug used to treat chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). It is a tyrosine kinase inhibitor (TKI) that works by blocking the activity of certain proteins that are involved in the growth and spread of cancer cells. Dasatinib is typically used in combination with other drugs to treat CML and Ph+ ALL. It is also used to treat other types of leukemia, such as myelodysplastic syndrome (MDS) and myelofibrosis. Dasatinib is available in both oral and intravenous formulations. It is typically prescribed as a first-line treatment for CML and Ph+ ALL, and is often used in combination with other drugs. Common side effects of dasatinib include nausea, vomiting, diarrhea, fatigue, and headache. Some companies in the dasatinib market include Bristol-Myers Squibb, Novartis, Pfizer, and Teva Pharmaceuticals. Show Less Read more